Homepage
Author:
Equillium, Inc.
Posted Date:
June 2, 2026
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Equillium, Inc.
June 2, 2026
Equillium to Participate in the 2026 Jefferies Global Healthcare Conference
Equillium, Inc.
May 28, 2026
Equillium to Host Virtual Investor Event to Share New Insights into the Aryl Hydrocarbon Receptor (AhR) and miR-124 Axis
Equillium, Inc.
May 20, 2026
Equillium Reports First Quarter 2026 Financial Results and Corporate Highlights
Equillium, Inc.
May 13, 2026
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Equillium, Inc.
May 1, 2026
Equillium to Participate in Oppenheimer’s 2026 Innovation on the Island Event
Equillium, Inc.
April 20, 2026
Equillium Announces Poster Presentations at IMMUNOLOGY2026™, the Annual Meeting of the American Association of Immunologists
Equillium, Inc.
April 8, 2026
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Equillium, Inc.
April 2, 2026
Equillium Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate and Clinical Highlights
Equillium, Inc.
March 25, 2026
Equillium to Participate in the 38th Annual Roth Conference
Equillium, Inc.
March 18, 2026
1
2
Next
